Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic retinopathy who have previously responded to at ...

High-dose HCQ use may lower the risk for diabetes among patients with pSS and can potentially mitigate the diabetogenic effects of glucocorticoids.

Hashimoto thyroiditis demonstrated a strong familial association between first-, second-, and third-degree relatives, especially among women.

Metabolic dysfunction-associated steatotic liver disease in pregnant women is a risk factor for preterm birth.

In adults with nonalcoholic fatty liver disease and obesity, the estimated glucose disposal rate strongly negatively correlated with liver fibrosis severity.

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

The US Food and Drug Administration has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines.

Intravenous thrombolysis in patients hospitalized for cervical artery dissection-related acute ischemic stroke increases the likelihood of home discharge.

Telangiectatic capillaries may have potential clinical relevance for diagnosis and treatment of diabetic macular edema.

A new White House report says today’s children are the sickest generation in U.S. history when it comes to chronic disease.

The prices charged at the US launch of targeted cancer therapies have increased well above the rate of inflation every year since 2012.